Episode Details

When courtroom expert testimony lacks scientific grounding, it risks stifling medical innovation and leaving patients without life-saving treatments. In New Jersey—a key hub for pharmaceuticals—judges are stepping in to act as gatekeepers, but federal standards remain stricter. Unreliable claims, often from overpaid specialists, can sway juries and deter companies from developing breakthrough therapies for cancer or rare diseases. The state’s Supreme Court recently clarified rules, but more work is needed to ensure only rigorously validated science influences verdicts—and ultimately, patient care.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/fa671cd347b9d3c9